FDA Approves Gemtuzumab Ozogamicin for CD33-positive AML

Drugs

Mylotarg (gemtuzumab ozogamicin) · Anti-CD33 antibody-drug conjugate, daunorubicin · Anthracycline, cytarabine · Pyrimidine analog

Condition

Myeloid